NecstGen BV Press Releases - EIN Presswire - Press Release Distribution Service

Published on February 10, 2025 - 08:00 GMT

NecstGen Partners with Galapagos to Advance Decentralised CAR-T Cell Manufacturing in Europe

NecstGen, a leading Contract Development and Manufacturing Organization (CDMO) dedicated to Cell and Gene Therapies, announces a collaboration with Galapagos NV LEIDEN, NETHERLANDS, February 10, 2025 /⁨EINPresswire.com⁩/ -- NecstGen, a leading Contract …

Distribution channels: Business & Economy, Education ...

Published on May 18, 2023 - 16:49 GMT

Cline Scientific announces LoI with NecstGen for the manufacture of its stem cell therapy for damaged cartilage

LEIDEN, SOUTH HOLLAND, NETHERLANDS, May 18, 2023 /⁨EINPresswire.com⁩/ -- Cline Scientific, a Swedish life science company developing a novel regenerative medicine, and NecstGen, a CDMO and centre of excellence for Cell and Gene Therapy, have signed a …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 8, 2022 - 17:28 GMT

Cell and Gene Therapies: bioMérieux partners with NecstGen

LEIDEN, SOUTH HOLLAND, THE NETHERLANDS, December 8, 2022 /⁨EINPresswire.com⁩/ -- bioMérieux and NecstGen, collaborate to accelerate the development of Cell and Gene Therapies (CGT) through the provision of ‘state of the art’ and rapid quality and safety …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on December 5, 2022 - 19:46 GMT

NecstGen Announces Major Milestone – GMP Manufacturing License

Today, the NecstGen team is happy to announce that is has received its GMP Manufacturing License! LEIDEN, SOUTH HOLLAND, NETHERLANDS, December 5, 2022 /⁨EINPresswire.com⁩/ -- 5 December 2022, Leiden, today the NecstGen team is happy to announce that is …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on November 23, 2022 - 15:15 GMT

Pan Cancer T and NecstGen Collaborate to Accelerate Novel TCR-T Therapies into Clinical Development

Pan Cancer T B.V., and NecstGen B.V., today announced a partnership to advance Pan Cancer T’s innovative therapies into the clinic. LEIDEN, SOUTH HOLLAND, THE NETHERLANDS, November 23, 2022 /⁨EINPresswire.com⁩/ -- Pan Cancer T B.V., a biotech spin-off …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on September 2, 2022 - 08:43 GMT

NecstGen Joins Major New Collaboration Project to Create Biointelligent Sensor for Improved Biomanufacturing

LEIDEN, SOUTH HOLLAND, THE NETHERLANDS, September 2, 2022 /⁨EINPresswire.com⁩/ -- As part of the Horizon Europe framework, NecstGen has joined an international consortium, that will work to develop Biointelligent Sensors for real time in production …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on June 3, 2022 - 08:06 GMT

NecstGen announces the opening of its Cell and Gene Therapy Manufacturing and Development facility

LEIDEN, SOUTH HOLLAND, NETHERLANDS, June 3, 2022 /⁨EINPresswire.com⁩/ -- On 1 June 2022, NecstGen’s brand-new GMP manufacturing and development facility for cell and gene therapies has been opened by Henri Lenferink (Mayor of Leiden), in the attendance of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...